EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Demand for human leukocyte antigen or human platelet antigen‐selected platelets: An observational study at Canadian Blood Services

Natasha Rickards, Phuoc-An Duong Hoang iD, Johnathan Mack, Matthew Seftel, John T Blake, Akash Gupta

Transfusion · 2026

DOI: 10.1111/trf.70025 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Transfusion, 2026. Verfasst von Natasha Rickards und 5 weiteren Autor:innen. Beteiligte Einrichtung: Medical Affairs Division, Canadian Blood Services, Ottawa, Canada. Hauptthemen laut MEDLINE: Platelet Transfusion, HLA Antigens, Antigens, Human Platelet, Blood Platelets. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Blood Services.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Platelet transfusion refractoriness (PTR) is a clinically important condition. The Human Leukocyte Antigen and Human Platelet Antigen (HLA/HPA) Platelet Program at Canadian Blood Services (CBS) provides platelet products to support such patients. This study provides a blood operator perspective on the provision of products for the management of immune‐mediated PTR (iPTR), including the evaluation of patient data to determine trends in the prevalence and diagnoses associated with iPTR. Study design and methods A retrospective observational study of patients enrolled in the CBS HLA/HPA Platelet Program between April 2021 and March 2025. Patient demographics and platelet product issuance were extracted from internal electronic records. Descriptive statistics were utilized for baseline characteristics and linear regression for temporal trends.

Results

We identified 788 cases representing 688 unique patients. Median patient age was 60.5 years. The most frequent diagnoses were acute leukemia (44%) and myelodysplastic syndrome (15%). HLA/HPA platelet issuance showed a statistically significant upward trend (average increase 23 units/quarter, p = .004). Platelet requests strongly predicted units issued ( R 2 = 0.92, p < .001), whereas the number of cases was a weak predictor for the number of platelets issued.

Discussion

The CBS HLA/HPA Platelet Program has experienced a rise in product demand. The strong relationship between product requests and issuance demonstrates the responsiveness of this program, though variability in fill rates and the limited predictive value of case counts highlight ongoing operational challenges. These findings can inform strategies for donor recruitment, inventory management, and case management to ensure reliable access to compatible platelets for sensitized patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Platelet TransfusionHLA AntigensAntigens, Human PlateletBlood PlateletsHumansCanadaFemaleMaleRetrospective StudiesMiddle AgedAgedAdult

Stichwörter der Autor:innen

alloimmunizationhuman leukocyte antigenspathogen reductionplatelet transfusion refractorinessthrombocytopenia

Substanzen

HLA AntigensAntigens, Human Platelet

Autor:innen und Institutionen

  • Medical Affairs Division, Canadian Blood Services, Ottawa, Canada.
  • Cancer Research Program, Ottawa Hospital Research Institute, Ottawa, Canada.
  • Division of Hematology, Department of Medicine, McGill University Health Center, Montreal, Canada.
  • Division of Hematology, Department of Medicine, University of British Columbia, Vancouver, Canada.
  • Dalhousie University, Halifax, Canada.
  • Department of Laboratory Medicine and Pathobiology, University of Toronto, Canada.

ORCID-Profile: Phuoc-An Duong Hoang

Förderung

  • Canadian Blood Services

Zitieren

APA

Rickards, N., Hoang, P. D., Mack, J., Seftel, M., Blake, J. T., & Gupta, A. (2026). Demand for human leukocyte antigen or human platelet antigen‐selected platelets: An observational study at Canadian Blood Services. Transfusion. https://doi.org/10.1111/trf.70025

Vancouver

Rickards N, Hoang PD, Mack J, Seftel M, Blake JT, Gupta A. Demand for human leukocyte antigen or human platelet antigen‐selected platelets: An observational study at Canadian Blood Services. Transfusion. 2026. doi:10.1111/trf.70025

BibTeX
@article{Rickards2026,
  author = {Rickards, Natasha and Hoang, Phuoc-An Duong and Mack, Johnathan and Seftel, Matthew and Blake, John T and Gupta, Akash},
  title = {Demand for human leukocyte antigen or human platelet antigen‐selected platelets: An observational study at Canadian Blood Services},
  journal = {Transfusion},
  year = {2026},
  doi = {10.1111/trf.70025}
}
Kostenlos starten →